Navigating an Expanded R/R Myeloma Landscape

 

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
P

Bispecifics in Multiple Myeloma

By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Patricia Mangan
By Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies FEATURING Patricia Mangan
305 views
August 11, 2023
0 Comments
Login to view comments. Click here to Login
Navigating an Expanded R/R Myeloma Landscape
26:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

Bispecifics in Multiple Myeloma

Feat. P. Mangan
16:42
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…

Feat. H. Hashmi
26:52
Naresh Bumma

Treatment Approaches for Heavily Pretreated R/R MM

16:07
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "What Is the Ideal Duration of Treatment in …

Feat. K. Yong
05:03
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Teclistamab in R/R MM - A Multi-Institution…

Feat. R. Chakraborty
14:59
Jeffrey Zonder

Managing Adverse Events of Bispecific Antibodies

22:14
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "RW Safety & Efficacy of Teclistamab for…

Feat. D. Dima
08:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outpatient Management of CAR-T and Bi-Speci…

Feat. R. Bansal